Investors in App

Scale-up Group likely provides expertise, connections, and support tailored for scaling up businesses. They may offer strategic advice, networking opportunities, and access to resources crucial for growth. Scale-up Group's focus could be on helping companies navigate challenges associated with expansion, such as funding, market penetration, operational scalability, and talent acquisition. Their services might appeal particularly to high-growth startups and scale-ups aiming to accelerate their growth trajectories and achieve market leadership. Scale-up Group's approach likely involves leveraging their extensive network and experience to provide customized support that addresses the unique needs of growing businesses.

The Dutch Sport Tech Fund represents a unique investment opportunity with a fund value ranging between 15 and 20 million euros, exclusively dedicated to the burgeoning sports technology sector. Anticipating significant growth, the sports tech market is projected to reach a value of 50 billion dollars by 2030. As the first fund of its kind, we focus on investing in promising companies poised for expansion within this dynamic market. Investors benefit from an expected annual ROI of ten percent, along with dividend payments and the absence of bank financing. With participation starting from €100,000, the Dutch Sport Tech Fund offers a gateway to capitalize on this explosive growth sector.

henQ is a venture capital firm that specializes in investing in early-stage B2B software startups across Europe. They are known for backing companies that are considered unconventional or "odd ones out" in their markets. henQ offers investment tickets ranging from €1M to €10M and takes a unique approach by not requiring startups to build traditional decks or models. Instead, they focus on meaningful conversations and fast decision-making. henQ is dedicated to providing deep support post-investment, ensuring startups grow efficiently and effectively.

Amatis, established in 2001, is a leading AI and cloud technology provider with over 20 years of industry experience. Specializing in innovative solutions across sectors like healthcare and fintech, Amatis combines digital expertise with strategic insights to transform business operations. The company's certified R&D center collaborates with global universities, integrating AI in e-health platforms for cardiology, dermatology, and sleep disorders, driving advancements in the Med-Tech field.

Pembroke VCT is a venture capital trust specializing in growth-stage companies across the health and fitness, apparel, media, and technology sectors. With a strategic focus on investing in high-potential ventures, Pembroke VCT supports companies poised for expansion and innovation. They provide not only financial investment but also strategic guidance and operational support to accelerate growth and achieve market leadership. Pembroke VCT's commitment to these sectors reflects their belief in the transformative impact of innovation and their dedication to fostering sustainable success in dynamic markets.

Since 2008, Accelerace has supported 1000+ Danish and international startups, including Trustpilot and Templafy and have made 120+ pre-traction investments. Our aim to help as many startups succeed as possible - by investing, making our platform available for free and offer mentoring from other successful founders.In Accelerace we stand on the shoulders of everyone we have had come through, and we use that knowledge to pass on to the next generation of startups. Accelerace is also responsible for the management of NOME (Nordic Mentor Network for Entrepreneurship), an elite mentoring program for Nordic life science startups, and are partners on programmes: Beyond Beta, VITA and Beyond.

Assay is an independent investment fund that invests in startups redefining everyday products and services, minimizing risks and maximizing profits through market-driven initiatives.We also provide business consulting services for entities that are interested in optimization and dynamic acceleration. Our goal is to invest in young, promising companies and support their development in a way that allows for maximizing operational competitiveness on the Polish and international market. First and foremost, we are interested in innovative and non-secondary solutions implemented in areas with high growth potential. Thanks to comprehensive and active support of the Portfolio, we strive to achieve rates of return that are rarely seen on the market.

Global healthcare company investing as Corporate VC in healthcare startups with a connection to the Beurer World of Health & Wellbeing. Next to a financial investment we are offering support along the whole supply chain (Co-Development, Production, Sales, etc.)

blisce/ is an investment firm co-headquartered in New York and Paris that is committed to investing differently. Pragmatically optimistic that entrepreneurship, innovation, and purposeful capital can improve our world, we empower people to take real action. We work to be genuinely aligned with all our stakeholders because we believe there is no acceptable financial performance without responsibility. Since 2014, blisce/ has invested in leading U.S. and European companies – including Spotify, Pinterest, Headspace, & Too Good To Go – with 8 exits. blisce/ was the first transatlantic fund to be certified as a B Corp.

We invest in boldly ambitious businesses, partnering with founders with vision, courage and the capacity to execute. We're experienced investors, we've invested in 35+ companies to date and in 2019 we launched our €80m third fund. We search for early-stage companies solving complex problems with breakthrough solutions. We have a European focus and invest in B2B opportunities in: cybersecurity, data and applications, infrastructure, devops, components and digital health.

Scientipole Ile-de-France Capital is a French venture capital firm specialized in funding seed stage companies. Scientipôle Capital invests in the innovative tech-based startups, at early stage. Team keeps a close relationship during the entire investment period to help entrepreneurs to succeed in all areas of management Scientipôle Capital is focused on innovative technologies developed in the Paris-Saclay area: • Solutions for the industry 4.0 : digital technologies, industrial technologies • Green tech applications to support energy and ecological transitions - smart grid, smart city • Health / medtech (except drugs) ...

Saab Ventures serves as the corporate venture arm of the group, established in 2001 to harness Saab's extensive engineering expertise. The primary objective of Saab Ventures is to facilitate the transition of Saab's innovative ideas and technology into independent companies. This initiative plays a pivotal role in fostering a culture of innovation within the organization.